Glycemic control is independently associated with rapid progression of coronary atherosclerosis in the absence of a baseline coronary plaque burden: a retrospective case-control study from the PARADIGM registry.
Cardiovasc Diabetol
2022
21
1
Changes in high-sensitivity troponin according to optical characteristics of neointima and treatment modality of In-stent restenosis
Eur Heart J
2022
43 Suppl 2
2012-2012
Extent of subclinical atherosclerosis on coronary computed tomography and impact of statins in patients with diabetes without known coronary artery disease: Results from CONFIRM registry.
J Diabetes Complications
2022
36
12
Age related compositional plaque burden by CT in patients with future ACS.
J Cardiovasc Comput Tomogr
2022
16
6
491-497
Early versus late acute coronary syndrome risk patterns of coronary atherosclerotic plaque.
Eur Heart J Cardiovasc Imaging
2022
23
10
1314-1323
Longitudinal Quantitative Assessment of Coronary Atherosclerotic Plaque Burden Related to Serum Hemoglobin Levels.
2022
2
3
311-319
Association Between Changes in Perivascular Adipose Tissue Density and Plaque Progression.
JACC Cardiovasc Imaging
2022
15
10
1760-1767
Longitudinal quantitative assessment of coronary atherosclerosis related to normal systolic blood pressure maintenance in the absence of established cardiovascular disease.
Clin Cardiol
2022
45
8
873-881
Aspirin and Statin Therapy for Nonobstructive Coronary Artery Disease: Five-year Outcomes from the CONFIRM Registry.
Radiol Cardiothorac Imaging
2022
4
2
Contrast agent volume for coronary computed tomography angiography imaging in current clinical practice.
J Cardiovasc Comput Tomogr
2022
16
2
191-193